Valuation : Celltrion, Inc.

Market Cap 43,392B 32.15B 27.73B 26.17B 23.82B 44.48B 3,069B 44.91B 312B 120B 1,561B 121B 118B 4,977B P/E 2026 *
27.4x
P/E 2027 * 23.5x
Enterprise Value 45.61B 33.79M 29.14M 27.5M 25.04M 46.75M 3.23B 47.2M 327M 126M 1.64B 127M 124M 5.23B EV / Sales 2026 *
8.26x
EV / Sales 2027 * 7.06x
Free-Float
60.59%
Yield 2026 *
0.42%
Yield 2027 * 0.46%
1 day-1.26%
1 week-2.95%
Current month-4.29%
1 month-9.28%
3 months+6.35%
6 months-6.94%
Current year+4.88%
1 week 180,100
Extreme 180100
190,000
1 month 180,100
Extreme 180100
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.26%-2.95%+12.00%+40.55% 32.79B
-0.56%-8.30%-5.88%+10.58% 46.38B
-2.08%-2.81%+396.70%+533.09% 44.51B
+0.12%-2.48%+35.68%+20.50% 42.3B
-2.62%-5.52%-2.66%+77.44% 39.91B
+0.16%-2.27% - - 17.13B
-0.54%-1.66%+20.09%+115.10% 16.36B
-0.03%-2.56%+10.88%+30.90% 14.31B
-1.92%-6.43%+73.47%+36.68% 13.29B
+3.87%+3.66%-1.92%-33.76% 12.31B
Average -0.49%-2.79%+59.82%+92.34% 27.93B
Weighted average by Cap. -0.87%-3.12%+78.65%+121.70%

Financials

2026 *2027 *
Net sales 5,518B 4.09B 3.53B 3.33B 3.03B 5.66B 390B 5.71B 39.62B 15.24B 199B 15.36B 15.02B 633B 6,337B 4.7B 4.05B 3.82B 3.48B 6.5B 448B 6.56B 45.5B 17.5B 228B 17.64B 17.25B 727B
Net income 1,536B 1.14B 981M 926M 843M 1.57B 109B 1.59B 11.03B 4.24B 55.24B 4.27B 4.18B 176B 1,785B 1.32B 1.14B 1.08B 980M 1.83B 126B 1.85B 12.81B 4.93B 64.21B 4.97B 4.86B 205B
Net Debt 2,215B 1.64B 1.42B 1.34B 1.22B 2.27B 157B 2.29B 15.9B 6.12B 79.67B 6.16B 6.03B 254B 1,355B 1B 866M 817M 744M 1.39B 95.84B 1.4B 9.73B 3.74B 48.74B 3.77B 3.69B 155B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-10 ₩180,800.00 -1.26% 742,053
26-09-09 ₩183,100.00 0.00% 372,393
26-09-08 ₩183,100.00 -1.72% 482,451
26-09-07 ₩186,300.00 -0.96% 408,399
26-09-04 ₩188,100.00 +0.53% 270,580
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
180,800.00KRW
Average target price
268,232.21KRW
Spread / Average Target
+48.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!